Question 1

What were the main findings from the previous study regarding the HPV vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults clinical trial (NCT00120848). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this follow-up study help me understand my health better?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults clinical trial (NCT00120848). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects I should be aware of from the vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults clinical trial (NCT00120848). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I have concerns about HPV or cervical cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults clinical trial (NCT00120848). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this study impact my overall health care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults clinical trial (NCT00120848). Contact the study team or your healthcare provider for specific answers.

What this study is about